Entry (T11) | Follow-up (T32) | |||||||
---|---|---|---|---|---|---|---|---|
Follow-up time | n | Mean | SD | Mean | SD3 | Effect size | p-value | |
NASS4 | ||||||||
Pain + disability | < 9 y | 63 | 2.97 | 0.67 | 2.67 | 0.85 | 0.46 | 0.004 |
≥ 9 y | 51 | 3.13 | 0.79 | 2.51 | 0.82 | 0.79 | < 0.001 | |
Neurogenic symptoms | < 9 y | 61 | 2.40 | 1.14 | 2.33 | 1.02 | 0.06 | 0.642 |
≥ 9 y | 51 | 2.42 | 1.05 | 2.34 | 1.25 | 0.08 | 0.638 | |
Short-Form 36 | ||||||||
Physical functioning | < 9 y | 59 | 62.98 | 17.15 | 61.18 | 22.38 | -0.11 | 0.476 |
≥ 9 y | 40 | 63.07 | 16.54 | 65.81 | 20.80 | 0.17 | 0.418 | |
Physical role | < 9 y | 59 | 47.74 | 39.11 | 47.88 | 43.87 | 0.00 | 0.646 |
≥ 9 y | 40 | 30.00 | 35.90 | 53.13 | 41.67 | 0.64 | 0.005 | |
Bodily pain | < 9 y | 59 | 40.53 | 14.22 | 51.92 | 20.81 | 0.80 | < 0.001 |
≥ 9 y | 40 | 36.38 | 14.97 | 56.33 | 19.86 | 1.33 | < 0.001 | |
General health | < 9 y | 59 | 54.34 | 16.26 | 53.03 | 19.84 | -0.08 | 0.541 |
≥ 9 y | 40 | 51.43 | 17.91 | 52.65 | 17.08 | 0.07 | 0.655 | |
Vitality | < 9 y | 59 | 48.73 | 15.13 | 50.17 | 19.45 | 0.10 | 0.508 |
≥ 9 y | 40 | 50.38 | 15.75 | 52.08 | 15.24 | 0.11 | 0.502 | |
Social functioning | < 9 y | 59 | 75.21 | 19.76 | 71.61 | 23.99 | -0.18 | 0.265 |
≥ 9 y | 40 | 69.69 | 24.82 | 77.81 | 18.67 | 0.33 | 0.042 | |
Emotional role | < 9 y | 59 | 83.62 | 30.56 | 71.19 | 43.09 | -0.41 | 0.022 |
≥ 9 y | 40 | 71.67 | 39.62 | 78.33 | 34.22 | 0.17 | 0.376 | |
Mental health | < 9 y | 59 | 67.93 | 15.96 | 68.07 | 17.71 | 0.01 | 0.951 |
≥ 9 y | 40 | 69.73 | 18.80 | 72.65 | 13.44 | 0.16 | 0.270 | |
Physical component summary | < 9 y | 59 | 36.18 | 8.13 | 37.97 | 10.30 | 0.22 | 0.166 |
≥ 9 y | 40 | 33.95 | 6.81 | 38.95 | 9.69 | 0.73 | 0.001 | |
Mental component summary | < 9 y | 59 | 51.01 | 8.90 | 48.86 | 11.51 | -0.24 | 0.086 |
≥ 9 y | 40 | 50.28 | 11.02 | 51.16 | 8.93 | 0.08 | 0.636 |